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Abstract: Multidrug resistant infections and superinfections are increasing globally. Intrinsic and acquired resistance to multiple
antibiotics by bacteria from the Enterobacteriaceae family exasperate treatment efforts by clinicians. Carbapenem antibiotics were
once relied upon to treat multidrug resistant infections. However, Carbapenem Resistant Enterobacteriaceae (CRE) infections are
becoming more common, requiring that an alternative treatment be found. This study trialed an ancient cure, Fresh Garlic Extract
(FGE) created from garlic (Allium sativum L.) and commercially prepared garlic pills against two opportunistic Enterobacteriaceae in
vitro utilizing: disc diffusion, well diffusion (introducing DIFF-bolts), and HPLC. FGE and four brands of garlic pills inhibited the
growth of Enterobacter cloacae and Klebsiella oxytoca in vitro. General Nutrition Center (GNC) brand were found to be the most
effective garlic pills producing comparable clear zones to meropenem (carbapenem antibiotic) for both bacteria. Garlicin produced
the next largest clear zones followed by Garlique and Nature made. Five out of nine garlic pill brands tested were not found to
contain viable allicin failing to produce clear zones in all microbial tests.
Keywords: Allicin, disc diffusion, DIFF-bolts, Enterobacter cloacae, garlic, garlic pills, Klebsiella oxytoca, well diffusion.

INTRODUCTION
Multidrug resistant infections and super infections affected over two million Americans last year [1]. Carbapenem
Resistant Enterobacteriaceae (CRE) is of particular concern as few other treatments are available to patients [2].
Recently in the news, multiple cases of CRE have been reported in hospitals across the country resulting in several
deaths [3]. The CDC has classified CRE at a threat level of “urgent” as a high fatality rate (about half of all infected
patients) is associated with these infections [4].
Enterobacter cloacae and Klebsiella oxytoca are opportunistic members of the Enterobacteriaceae family [5]. Both
are facultatively anaerobic, gram-negative rods which are normal intestinal flora of humans and generally nonpathogenic to their host [6]. However, once released from their host in a nosocomial setting they may become
pathogenic infecting immunocompromised individuals via biofilms on medical equipment or other fomites [6, 7].
Enterobacteriaceae bacteria possess intrinsic (innate) resistance to beta lactam antibiotics and can acquire resistance
* Address correspondence to these authors at Department of Biology, Stephen F. Austin State University, Nacogdoches, TX 75962, USA; E-mails:
Cindysbirdsandbooks@yahoo.com, dgravatt@sfasu.edu
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to multiple other types of antibiotics from enzymes called “extended spectrum beta lactamase (ESBLs)” transferred via
plasmid from other bacteria [8 - 10].
Carbapenem antibiotics such as imipenem and meropenem are broad spectrum antibiotics capable of inhibiting beta
lactamase producing bacteria; allowing them to treat infections when other antibiotics had failed; earning them the
name “the antibiotic of last resort” [4, 11, 12]. However, this group of antibiotics are also subject to resistance and CRE
infections began to emerge more than a decade ago leaving many patients today without a viable cure [12].
Garlic (Allium sativum L.) is a bulbous herb from the family Liliaceae which is often used as a food flavor enhancer
or topping [13]. This herb is thought to possess potent antimicrobial properties and therefore has been utilized as a
medicine for centuries [14]. Most of the anti-microbial properties of garlic are attributed to a component called “allicin”
(allyl 2- propenethiosulfinate) [15]. Allicin has fewer side effects than traditional antibiotics, there is less chance of
resistance, and it is inexpensive to create.
The aim of this study was to determine via disc and well diffusion microbiological testing (compared to HPLC),
whether fresh garlic extract (FGE) or commercially prepared garlic pills inhibited the growth in vitro of either
Enterobacter cloacae or Klebsiella oxytoca.
MATERIALS AND METHODS
Organisms and Cultures
Rehydrated cultures of E. cloacae (ATCC) 23355 and K. oxytoca (ATCC) 8724 obtained from Hardy Diagnostics in
Santa Maria, CA, USA. were utilized for the bacterial cultures. A loop-full of each pure culture was added to glass
bottles of sterile nutrient broth and then grown for 24 h at 37 oC. Turbidity was adjusted with a BioTek µQuant Spectrophotometer - 90 mL bacterial culture to 600 mL nutrient broth for E. cloacae and 100 mL bacterial culture to 100 mL
nutrient broth for K. oxytoca. Inoculum was added to plates via pipette, 125 µL for standard plates and 400 µL for large
plates.
Media and Microbial Plates
Media
Mueller Hinton Agar base for antimicrobial disc diffusion susceptibility testing, 500 g, Lot 142697. Cultures for
spread plates were grown overnight in Difco Nutrient broth- Lot 7239160. Microbial Plates Standard size petri dishes
(100 × 15 mm) from VWR International were utilized for disc and well diffusion- as well as larger 150 × 15 mm
disposable polystyrene petri dishes from USA Scientific, Ocala, FL, USA.
Kirby-Bauer Disc Diffusion (KBDD)
Standard procedure for the Kirby-Bauer Disc Diffusion Method was followed [16]. Diffusion discs - 6 mm blank
paper diffusion discs - from Becton, Dickinson and Company (BDL), Sparks, MD 21152, USA. Lot 4034351 exp.
2019-02-28. Blank discs were soaked in treatments (dissolved garlic pills or FGE) for two minutes. Diffusion discs
were then applied to the plates with sterile autoclaved forceps. Multiple treatments were placed on the same large 150 ×
15 mm plate for comparison purposes including a meropenem positive control and a water negative control. Spread
plates were inverted and incubated for 30 min prior to the addition of treatment discs. Note plates were not inverted
overnight.
Well Diffusion (WD)
In 1997, Sylvia Magaldi a Venezuelan researcher, developed the well diffusion (WD) technique which utilizes agar
wells instead of paper discs [17]. Well diffusion (aka cup plate) allows researchers to test much larger doses and
therefore has the potential to create much larger clear zones. Other trials have utilized cork borers and like equipment to
produce wells. We noted that these methods left the plate open long enough to possibly allow contaminants to enter the
plates. Thus, we developed stainless steel diffusion bolts (DIFF-bolts) that fit inside the plate allowing the plate to
remain closed for most of the process (Fig. 1). These bolts produced a much larger well than past methods, which in
turn created very large clear zones (Table 1). Stainless steel was used to create the DIFF-bolts because it is not as
reactive as other metals and is easy to clean. 2.54 cm DIFF-bolts were utilized for most of the study as the 1.91 cm were
too light and at times would float out of position causing odd looking wells.
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Diffusion Bolts (DIFF-Bolts)

Fig. (1). DIFF-bolts two sizes were trialed 2.54 cm and 1.91 cm. The SFASU DIFF-bolt development team included: Lucinda
Choules, Dr. Dennis A. Gravatt, Clay Watts and Ron Havner.

Table 1. DIFF-bolt Specifications.
2.54 cm DIFF-bolt

1.91 cm DIFF-bolt

2.54 cm outside diameter

1.91 cm outside diam.

height 1.36 cm,
weight - 53.44 g
well diameter 2.6 cm

height 1.36 cm,
weight - 30.07 g
well diameter 1.8 cm

top groove 0.23 cm wide 0.006 cm deep
bottom of bolt not polished

top groove 0.23 cm wide, 0.006 cm deep bottom of bolt not polished

DIFF-Bolt Procedure
Autoclaved diffusion bolt/s were placed in the center of the plate with sterile forceps and agar was poured around
the bolt (Fig. 2) (note: when using large plates more than one DIFF-bolt can be utilized on the same plate), the lid
closed, and the plate monitored closely from the outside for a change in opacity. When this change was evident and the
agar appeared solid, the DIFF-bolt was removed with sterile autoclaved forceps leaving a round well (Figs. 3, 4).

Fig. (2). DIFF-bolts are placed in the center of the plate and agar poured around the bolts (Note: the agar solidifies with the plate
closed. Thus, it will reduce possible contaminant issues).
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Fig. (3). Photo of Lucinda Choules removing a DIFF-bolt by Ravaen Slay.

Fig. (4). When the agar solidifies the diffusion bolt is removed leaving a round well behind (Note: the wells are not always as clear
as the well pictured above as bits of agar are often left behind on the bottom of the well).

Caution
Removing the bolt too early may result in the well filling back in. Conversely, waiting too long to remove the bolt is
also problematic as the bolt may adhere to the agar making it difficult to remove. Designing specialized forceps or
modifying existing forceps to help with DIFF-bolt removal would be advantageous.
Then, inoculum was spread over the agar, the specified treatment added to the well via disposable glass Pasteur
pipette and the plates incubated (not inverted) at 37 oC for 24 h.
A future modification to the DIFF-bolt design may be required in order to produce wells without bits of agar at the
bottom. For example, using a pipe instead of a rod may release the vacuum created by removing the bolt. However, if
the pipe is too light it could float out of position before the agar hardens. This problem may be solved by drilling a hole
through the center of a regular DIFF-bolt.
Treatments
Fresh Garlic Extract (FGE)
This study utilized Spiceworld brand, Orlando, FL fresh garlic purchased from Wal-Mart. FGE was created in 50
mL sterile test tubes and allowed to develop between 2 and 4 h depending on the study. Three random bulbs were
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utilized for each trial. The Spiceworld bulbs varied greatly in size and weight, from 22-37 g, bulbs utilized for this study
weighed approximately 27-32 g. Two cloves from each bulb were crushed in an autoclaved garlic press (total of six
cloves). Each 50 ml test tube was filled with 30 mL of autoclaved Gerber water (purified via reverse osmosis) and then
the cloves were crushed with an autoclaved garlic press into each test tube. The very outer white covering of each clove
of garlic was removed, but parts of subsequent beige outer layers were added to the test tubes. Water was added to fill
the tube to the 48-50 mL mark. Weight of garlic tubes averaged 61-65 g (including weight of tube). Depending upon
how much water and peel was added. 50 mL tubes were then closed with the lid and left at room temperature for 2-4 h
to facilitate allicin production.
Meropenem
The Disc diffusion trials utilized meropenem discs - Sensi Disc Susceptibility test 10 µg lot 4210973 exp.
02/29/2016 from Becton, Dickinson and Company, Sparks, MD, USA.
Well Diffusion
25 mg Meropenem Sodium Carbonate powder from LKT laboratories Lot 2597783 obtained from Fischer Scientific
was rehydrated by adding 2 mL autoclaved Gerber water to the vial provided by LKT containing the antibiotic powder.
Then the vial was capped and shaken until the antibiotic dissolved. 100 µL of hydrated meropenem was added via
pipette to 3 mL of autoclaved Gerber water. All treatments were inoculated into the agar wells via disposable heavy
wall glass 5¾ Pasteur pipets from VWR Scientific, San Francisco, CA, USA.
Garlic Pills
Pill Preparation
10 mL of autoclaved Gerber water was added to the 15 mL test tube initially- 3 pills of each brand were crushed
with a sterile mortar and pestle and then added to a the 15 ml plastic test tube. Weight of pills for each lot of 3 pills are
as follows: GNC 5.52 g, Garlicin Cardio 1.99 g, Garlique 2.09 g, Nature Made 1.87 g. Since number of pills rather than
weight were evaluated in this study, the results for some of the viable garlic pills such as Garlicin may be underreported
as Garlicin produced large clear zones for its size and thus if equal weights of pills were trialed may produce
comparable or superior results to GNC. However, weight is clearly not the only factor as Garlicin was lighter than
Garlique but produced much larger clear zones. Future studies should investigate equal weights of pills in order to see if
the rank changes.
Additional Gerber water was added to fill each tube to the 15 mL mark. All tubes were then sealed with the lid and
shaken, manually or by machine until the pills dissolved. When the pills were completely dissolved they were added to
the wells with a Pasteur pipette. Additional pills were purchased when needed. The new pills produced similar results to
the originals.
Each garlic pill was assigned a number randomly prior to the initiation of the study. Nine brands of garlic pills were
evaluated in this study: Ten pills were tested (Table 2).
Table 2. Effective garlic pills by randomly assigned experimental number.
Garlic Pill Brand
Nature Made

Number
1

Garlique

3

Garlicin

5

GNC

7

GNC 1100

10

(Note: Ineffective pills 2, 4, 6, 8, and 9 have been excluded from the table above).

Quantification of Allicin Content via HPLC
All 9 garlic pill brands and FGE were tested for presence or absence of allicin peaks via HPLC. Diluted garlic pills
were filtered into Target polypropylene 45 µM vials and 1000 µL of each treatment was run through the filter into each
vial until the sample vials were half full. The samples were then subjected to HPLC analysis- Agilent 1260 HPLC
system, Eclipse 5 μm XDB-C18 column, 0.6 mL/min, 22% acetonitrile in water, 254 nm [18].
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RESULTS
GNC 1000 exhibited a high pH similar to water, while the pH of the other effective pills was much lower, closer to
that of fresh garlic extract (Table 3).
Table 3. Average pH of the solutions for effective treatments.
Treatment
Garlic pill 1

Average pH reading
5.58

Garlic Pill 3

5.32

Garlic Pill 5

5.95

Garlic Pill 7

7.31

FGE

6.00

Gerb water

7.40

Meropenem produced the largest clear zones (Figs. 5, 6). But GNC produced statistically similar sized clear zones
to meropenem and larger clear zones than FGE in disc diffusion trials (Fig. 7, Table 4). Garlicin was the second most
effective garlic pill followed by Garlique and Nature made which produced similar sized clear zones.
Table 4. Disc diffusion of different garlic products (S.D.: standard deviation.
E. cloacae
Treatment

n

Mean (mm)

S.D.

Meropenem

9

20.55

2.709

GNC 1000

11

19.09

3.254

FGE

11

16.31

1.944

Garlicin

10

12.39

2.027

Garlique

10

11.75

0.950

Nature Made

10

10.25

1.399

K. oxytoca
Treatment

n

Mean (mm)

S.D.

Meropenem

16

26.62

3.981

GNC 1000

15

22.57

2.374

FGE

16

18.69

3.291

Garlicin

16

15.97

2.802

Garlique

16

12.06

1.263

Nature Made

15

11.30

1.251

Fig. (5). shows disc diffusion on large K. oxytoca plate for all treatments. Top left is meropenem, top right is GNC 1000 (Note: they
produced very similar sized clear zones). Middle is FGE, next line Garlicin (left), Garlique (middle) and Nature Made (right). None
of the pills on the bottom row produced a clear zone).
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Fig. (6). In the graph above the average clear zones for all samples are compared. GNC 1000 produced similar sized clear zones to
meropenem for both bacteria.

65

55
Zones (mm)

Well Dif

Well Diff

45

35

Fig. (7). In the bar graph above, Fresh garlic (FGE) in a larger dose produced clear zones that were slightly larger than meropenem
this is not the case for the very fastidious E. cloacae plates where FGE ranked only fourth. GNC 1100 produced larger clear zones
than GNC 1000 for both bacteria (Note: GNC 1100 produced statistically similar sized clear zones to that of meropenem).

Well Diffusion
GNC 1100 was trialed in the larger dose well diffusion trials and was found to produce slightly larger clear zones
than GNC 1000 which rivaled the clear zones produced by meropenem at times on the K. oxytoca plates (Fig. 8, Table
5).
Table 5. Well diffusion of different garlic products (S.D.: standard deviation).
E. cloacae
Treatment
Meropenem

n

Mean (mm)

S.D.

7

49.29

2.941

GNC 1100

7

47.43

2.490

GNC 1000

7

46.82

6.107

FGE

6

45

3.768

Garlicin

7

41

5.773

Garlique

6

38

5.366

Nature Made

6

36.67

3.076

K. oxytoca
Treatment

n

Mean (mm)

S.D.

FGE

5

56.5

8.448

Meropenem

6

56.25

3.474
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(Table ) contd.....

E. cloacae
Treatment
GNC 1100

n

Mean (mm)

S.D.

5

50.90

4.129

GNC 1000

6

49.92

3.813

Garlicin

7

46.93

7.091

Garlique

6

40.83

3.669

Nature Made

6

40.58

5.304

Fig. (8). GNC 1100 results on standard sized plates (left) compared to meropenem (right) (Note: the similar sized clear zones
produced on the K. oxytoca plates).

E. cloacae grew many times faster than K. oxytoca. Thus, all of the treatments produced smaller clear zones on the
E. cloacae plates. However, the zones while smaller were more consistently uniform in shape and very clear as is
illustrated above in Fig. (9).
Statistical Analysis
The statistical analyses were created with SAS JMP software (SAS, 2015). The p values were found to be < .0001
for both disc and well diffusion. Thus, statistically significant differences were found between the treatments. Tukey
tests showed that meropenem and GNC were statistically similar for both disc and well diffusion testing on E. cloacae
plates and well diffusion K. oxytoca plates. However, a statistical difference was noted for disc diffusion trials on K.
oxytoca plates.

Fig. (9). GNC 1000 clear zone on E. cloacae plate.

Ineffective Garlic Pills
The HPLC chromatograph below Fig. (11) Depicts the allicin peaks for each of the effective garlic pills. These
results show an identical ranking to the microbial studies. GNC produced the largest peak, with the size of the wave
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decreasing for each subsequent effective pill. Later, HPLC analysis showed smaller peaks for Nature made and Garlicin
as they degraded over time. No allicin peaks were visible for the five ineffective pills which is illustrated in the last line
of the chromatograph above for garlic pill 2.

Fig. (10). Four of the five ineffective garlic pills tested are pictured above on E. cloacae-no clear zones were noted for these pills
despite allicin claims on the packaging of all but one of these brands.

HPLC

Fig. (11). HPLC chromatograph of garlic pills. First line of graph is garlic pill 7 (GNC 1000): 2nd line Garlic pill 5 (Garlicin), third
line Garlic pill 3 (Garlique), fourth line garlic pill 1 (Nature Made) last line ineffective Garlic pill 2.

DISCUSSION
The results of this study clearly show that E. cloacae and K. oxytoca were highly susceptible to allicin in vitro and
that one brand of garlic pill GNC consistently produced statistically similar sized clear zones (19 mm for E. cloacae, 22
mm for K. oxytoca) to that of meropenem (20.5, 26.62 mm) during disc diffusion trials. FGE created smaller clear zones
(16.3, 18.6 mm) during disc diffusion trials but produced much larger clear zones (46.8, 56.5 mm) in the higher dose
well diffusion trials surpassing even meropenem (49.29, 56.25 mm) in the treatment of slower growing K. oxytoca. The
efficacy rank of the effective garlic pill brands remained the same throughout the study (from highest efficacy to
lowest): (1) GNC, (2) Garlicin, (3) Garlique, and (4) Nature Made.
GNC 1000 was utilized for both disc and well diffusion trials. GNC 1100 was added later to the well diffusion trials
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in order to determine if the more expensive 1100 pills produced equivalent or better clear zones to that of GNC 1000.
GNC 1100 clear zones averaged about one mm higher (47.43, 50.90 mm) than that of GNC 1000 (46.82, 49.92 mm).
Thus, GNC 1100 was found to exhibit slightly higher efficacy during microbial testing than GNC 1000 and therefore,
may be worth the additional cost to the consumer.
HPLC results were consistent with the micro results for newly purchased pills. Allicin peaks on the chromatogram
were largest for GNC garlic pills; with peaks decreasing for each effective pill. The rank of the pills was identical to the
micro results for newer pills. However, expiration and product degradation issues were evident for older pills during
HPLC testing, with allicin peak area decreasing over time. Many of the brands degraded well before their listed
expiration dates, thus manufacturers should endeavor to revise their shelf life testing SOPs.
Five of the nine brands of garlic pills evaluated in this study were found to be completely ineffective against both
species of bacteria failing to produce clear zones during microbial testing (Fig. 10) or to create an allicin peak during
HPLC testing (Fig. 11). Whether or not the makers of these garlic pills knowingly produced ineffective pills is unclear;
it is possible that some of these companies were using appropriate raw materials but inadvertently deactivated the allicin
via erroneous processing methods such as improper freeze drying protocols or by overheating the garlic [19 - 21].
However, deliberate efforts to mislead consumers by one or more of these manufacturers are also a consideration as
herbal remedy producers are not federally regulated and this is a highly competitive multi-million dollar industry.
Recently, the NY Attorney General’s office DNA tested herbal products and found that many herbal remedies sold at
large retailers such as Wal-Mart and Target did not contain any of the herb listed on the packaging [22]. Instead, these
pills were found to be full of fillers and contaminants such as: “rice, alfalfa, and even house plants” [22].
Our study, similarly found that what was written on the packaging did not necessarily match the product when
examining the presence or absence of viable allicin. Many of the garlic pill brands claimed to contain allicin but five of
the garlic pill brands were not found to contain viable allicin. Of these five, only one did not make an allicin claim.
Confoundedly, half of the effective pills including the most effective brand GNC which should have an allicin claim,
failed to make one. Thus, if a consumer were to choose a brand with an allicin claim at the store, that specific brand is
more likely not to contain viable allicin than a brand without an allicin claim.
GNC brand was found to be the most effective out of nine brands of garlic pills. GNC 1100 were the most effective
pills, and their enteric coating may confer viability in vivo. Other studies have shown that allicin is destroyed by
digestive juices in the stomach and therefore enteric coatings are required, in order to get the allicin past the stomach to
the intestines [23]. Despite this fact, some of the garlic pills on the market are not yet enteric coated.
This study was multidisciplinary, thus our research was not just confined to the laboratory. Part of our study
surveyed SFASU students and faculty about their views toward herbal remedies, 68% of people stated they would
prefer to take two smaller pills rather than one large pill. However, most of the garlic pill manufacturers evaluated in
this study, exclusively produced larger pills. Thus, in so doing, they are completely disregarding the preferences of a
huge demographic of customers. Moreover, they are failing to benefit from an emerging mega market of non-human
customers. Poultry producers have been ordered to phase out antibiotics in production. Thus, an industry savvy garlic
pill producer should endeavor to produce tiny, round, effective, sugar and enteric coated garlic pills designed
specifically for poultry. Color is important in order to get chickens to eat pills on their own. An earlier color preference
study by one of the authors of five flocks of backyard chickens found that they overwhelmingly preferred white, orange,
or red bread dots to all other colors (unpublished study by Lucinda Choules).
In Conclusion, the fact that GNC garlic pills produced statistically similar clear zones to that of meropenem is
highly significant for carbapenem resistant Enterobacteriaceae patients and in vivo trials should be initiated with GNC
1100 garlic pills for CRE patients as few other viable treatments are currently available to them. Garlic produces very
few side effects (mostly blood thinning or food allergies). Thus, garlic can be safely trialed even on critically ill
patients.
Moreover, many studies have noted a synergistic affect between garlic and antibiotics, thus it might be prudent to
conduct study trials combining garlic pills with the new CRE antibiotic AVYCAZ (ceftazidime-avibactam) in order to
check for a potential synergistic affect [24].
CONCLUSION
Disc and well diffusion bioassays found commercially prepared garlic pills exhibited significantly different
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activities against E. cloacae and K. oxytoca in vitro. Of the nine tested garlic pill brands, only four brands showed
bioactivities. GNC garlic pills created statistically similar clear zones to Meropenem and FGE. HPLC analysis of active
allicin supported bioassay results.
ABBREVIATIONS
AVYCAZ

=

Ceftazidime-avibactam
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=

Becton, Dickinson and Company

CDC

=

Centers for Disease Control and Prevention
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Carbapenem resistant Enterobacteriaceae

DIFF-bolts

=
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=
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=

High performance liquid chromatography
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=
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